>Q3: revenues up 5.9% organically - Q3 revenues came in at € 195.9m, up 10.9% (+5.9% organically.For the 9 months to 30 June 2010, operating revenue amounted to € 582.2m, up 9.1% (8.2% organic growth or 5.8% organic growth restated for the Ségur measures, booked as a reduction in personnel costs in 2023).The company is maintaining its guidance (+5% organically), in an environment it describes as “a difficult environment caused by the reform of SMR pricing”, ...
>T3 : organique à +5,9%... - Le CA T3 de LNA Santé ressort à 195,9 M€, soit +10,9% (+5,9% organique).A 9 mois, le CA Exploitation se monte à 582,2 M€, soit +9,1% (+8,2% organique ou +5,8% organique retraité des mesures Ségur, comptabilisées en réduction des charges de personnel en 2023).La société maintient sa guidance (+5% organique), dans un environnement qu’elle qualifie de « difficile, provoqué par la réforme de la tarification des SMR », avec, en effet,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.